To further characterize the molecular mechanism by which DCP2 negatively regulates SCLC chemotherapy resistance, we performed GO pathway enrichment analysis on our m6A-seq data and found that the mitochondrial autophagy pathway was highly enriched. Here, DCP2 is linked to small cell lung carcinoma.